Back to Search Start Over

Orion is developing an immuno-oncology (IO) drug discovery platform in the national research and innovation consortium Cancer IO

Source :
Legal Monitor Worldwide. June 5, 2020
Publication Year :
2020

Abstract

(GlobeNewswire) - ORION CORPORATION PRESS RELEASE 4 JUNE 2020 at2.30 p.m. EEST Orion is developing an immuno-oncology (IO) drug discovery platform in the national research and innovation consortium Cancer IO [...]

Subjects

Subjects :
Orion Corp. -- Innovations
Consortia -- Research
Cancer
Industrial equipment industry -- Innovations -- Research
Cancer research
Immunotherapy -- Research
Drug discovery -- Research
Health
Consortium
Business, international
Law

Details

Language :
English
Database :
Gale General OneFile
Journal :
Legal Monitor Worldwide
Publication Type :
News
Accession number :
edsgcl.625796687

Tools

Authors Abstract Subjects Details